Exclusive By Nicholas Florko and Lev Facher Longtime Becerra aide and two health policy experts to be tapped for key posts
Exclusive By Damian Garde Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine
Exclusive By Adam Feuerstein Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says
Exclusive By Lev Facher Biden’s Covid-19 team reconsiders pandemic plan in light of more infectious coronavirus variants
Exclusive By Matthew Herper Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
Exclusive By Lev Facher Leading Covid-19 vaccine makers Pfizer and Moderna decline invitations to White House ‘Vaccine Summit’
Exclusive By Nicholas Florko New document reveals scope and structure of Operation Warp Speed and underscores vast military involvement
Exclusive By Nicholas Florko Trump officials actively lobbied to deny states money for vaccine rollout last fall
Exclusive By Olivia Goldhill Undercounting of Covid-19 deaths is greatest in pro-Trump areas, analysis shows
Exclusive By Nicholas Florko In a last-minute, intra-agency scuffle, HHS overrules FDA pick for a key position
Exclusive By Olivia Goldhill Pfizer decision to turn off temperature sensors forced scramble to ensure Covid-19 vaccines kept ultra-cold
Exclusive By Erin Brodwin CommonHealth, the Android answer to Apple Health Records, expands to 230 health systems
Exclusive By Lev Facher White House to host Covid-19 vaccine summit, as Trump seeks to burnish record
Exclusive By Helen Branswell Divisions emerge among U.S. officials over when first Covid-19 vaccine doses will be available — and for whom
Exclusive By Matthew Herper and Damian Garde Raging at the pandemic, a VC raises $800M for a company that aims to transform biotech manufacturing
Exclusive By Ed Silverman STAT-Harris Poll: Most Americans won’t get a Covid-19 vaccine unless it cuts risk by half
Exclusive By Ed Silverman STAT-Harris Poll: The share of Americans interested in getting Covid-19 vaccine as soon as possible is dropping
Special Report By Lev Facher First-of-its-kind examination shows how widely pharma showers campaign cash at the state level
Exclusive By Damian Garde and Adam Feuerstein Selling stock like clockwork, Moderna’s top doctor gets $1 million richer every week
Exclusive By Alison Insinger Top health official echoes Trump’s Covid-19 views, drawing accusations of politicizing U.S. mental health agency
Exclusive By Rebecca Robbins, Adam Feuerstein, and Helen Branswell AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
Exclusive By Nicholas Florko and Lev Facher PhRMA scrambles to respond to Trump’s drug pricing ultimatum, as Monday deadline looms
Exclusive By Helen Branswell, Kate Sheridan, Casey Ross, and Andrew Joseph The Trump administration haphazardly gave away millions of Covid-19 masks — to schools, broadcasters, and large corporations
Exclusive By Nicholas Florko FDA’s reopening plan will keep biologics labs shuttered far longer than other government labs
Special Report By Lev Facher Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Exclusive By Nicholas Florko In unusual arrangement, deputy HHS secretary’s wife has been lobbying the agency on behalf of health care companies
Exclusive By Matthew Herper and Erin Riglin Data show panic and disorganization dominate the study of Covid-19 drugs